Shopping Cart
Remove All
Your shopping cart is currently empty
SSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $33 | Inquiry | Inquiry | |
| 5 mg | $73 | Inquiry | Inquiry | |
| 10 mg | $118 | Inquiry | Inquiry | |
| 25 mg | $273 | Inquiry | Inquiry | |
| 50 mg | $403 | Inquiry | Inquiry | |
| 100 mg | $573 | Inquiry | Inquiry | |
| 200 mg | $778 | Inquiry | Inquiry | |
| 1 mL x 10 mM (in DMSO) | $80 | Inquiry | Inquiry |
| Description | SSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2). |
| Molecular Weight | 300.36 |
| Formula | C16H20N4O2 |
| Cas No. | 883944-52-3 |
| Smiles | CN1CCN(CC1)c1ccc(CNC(=O)c2ccno2)cc1 |
| Relative Density. | 1.202 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 230 mg/mL (765.75 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (10.99 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.